PTAB statistics

PTAB Trial Statistics as of August 31, 2017

As of August 31, 2017, USPTO records show 7,447 AIA trial petitions filed since September 16, 2012 (6,831 IPR, 524 CBM, 74 PGR, 18 derivation). The Board had instituted trial on 3,571 petitions and denied 2,379 (60.0% instituted) and had issued 2,018 final written decisions. In fiscal year 2017 to that date, 1,777 petitions were filed.

Key Facts

As of
August 31, 2017
Fiscal year
FY2017
Petitions filed (cumulative)
7,447
Institution rate (cumulative)
60.0%
Petitions filed (FY2017 to date)
1,777
Data retrieved
October 31, 2026
On this page
  1. Cumulative Figures as of August 31, 2017
  2. Fiscal Year 2017 to Date
  3. Change Since February 28, 2017
  4. Trial Types Covered
  5. How These Figures Were Compiled
  6. Related Statistics

This page gives Patent Trial and Appeal Board trial figures as of August 31, 2017, which falls in fiscal year 2017 (October 1, 2016 to September 30, 2017). The cumulative figures run from September 16, 2012, when AIA trials began. The full year is covered on the FY2017 statistics page.

Cumulative Figures as of August 31, 2017

Events from September 16, 2012 to August 31, 2017, by trial type:

MeasureIPRPGRCBMDERTotal
Petitions filed6,83174524187,447
Institution decisions: instituted3,2602428703,571
Institution decisions: denied2,1581919752,379
Institution rate (by petition)60.2%55.8%59.3%0.0%60.0%
Final written decisions1,827918202,018
Terminations without a final written decisionCount
Settlements1,068
Adverse judgment0
Dismissed1
Other terminations287

Fiscal Year 2017 to Date

Events from October 1, 2016 to August 31, 2017:

MeasureIPRPGRCBMDERTotal
Petitions filed1,688374841,777
Institution decisions: instituted74110240775
Institution decisions: denied46810292509
Institution rate (by petition)61.3%50.0%45.3%0.0%60.4%
Final written decisions5766300612
Terminations without a final written decisionCount
Settlements369
Settled before institution185
Settled after institution184
Adverse judgment0
Dismissed1
Other terminations186

Change Since February 28, 2017

Between the previous dated page (February 28, 2017) and August 31, 2017, 921 petitions were filed, 439 trials were instituted, 305 petitions were denied institution and 331 final written decisions issued. The cumulative institution rate moved from 60.2% to 60.0%.

Trial Types Covered

6,831 of the 7,447 petitions (91.7%) were for inter partes review, which challenges patent claims on prior-art grounds under 35 U.S.C. chapter 31. The remainder were for covered business method review (524), post-grant review under chapter 32 (74) and derivation proceedings (18). Institution standards differ by proceeding; see the threshold standards.

How These Figures Were Compiled

The figures are counted from USPTO Open Data Portal records retrieved on October 31, 2026, keeping only events dated on or before August 31, 2017: a petition by its filing date, an institution decision by its decision date, and a final written decision or termination by its date. They are a reconstruction from the current records, not the USPTO’s report of that date, and may differ from statistics the USPTO published at the time. Final written decision outcomes are not reported because the records state them for too few decisions. The methodology gives the counting rules in full.

Frequently Asked Questions

How many AIA trial petitions had been filed as of August 31, 2017?

USPTO records show 7,447 petitions filed from September 16, 2012 to August 31, 2017: 6,831 IPR, 524 CBM, 74 PGR and 18 derivation.

What was the PTAB institution rate as of August 31, 2017?

Cumulatively, 60.0% by petition: 3,571 instituted and 2,379 denied. In FY2017 to that date the rate was 60.4%.

Primary Sources

  1. USPTO Open Data Portal (PTAB trial proceedings and decisions data)
  2. USPTO Patent Trial and Appeal Board statistics
  3. 35 U.S.C. chapter 31 (inter partes review)
  4. 35 U.S.C. chapter 32 (post-grant review)
  5. 37 C.F.R. Part 42 (trial practice before the PTAB)

Educational information; not legal advice. Statutes, rules and USPTO practice change. Confirm against the primary sources and consult a registered patent practitioner before acting. Disclaimer.